34 completed, 11 unknown, 3 recruiting, 2 not yet recruiting. 20 Phase 3, 13 Phase 4, 6 Not applicable, 5 Phase 1, 4 Phase 2.
Follow iron isomaltoside 1000: new trials by email Literature Review of iron isomaltoside 1000 trials Research Report on iron isomaltoside 1000
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study Monofer (iron isomaltoside 1000), Ferrous Sulfate - Peritoneal Dialysis, Anaemia | Phase 3 | Recruiting | Hull University Teaching Hospitals NHS Trust | 30 | 2025-11-13 | 2026-05-06 |
| Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency. Iron Isomaltoside injection, Physiological saline solution (as placebo) - Obesity, Anemia | Not applicable | Recruiting | China-Japan Friendship Hospital | 200 | 2025-03-01 | 2025-11-19 |
| Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients Iron isomaltoside, Ferrous succinate - Renal Anemia, Peritoneal Dialysis (PD) | Phase 4 | Not yet recruiting | Xie Jingyuan, MD | 124 | 2025-02-15 | 2025-02-17 |
| IV Iron-induced Hypophosphatemia After RYGB Iron isomaltoside, Iron Carboxymaltose - Hypophosphatemia, Roux-en-Y Gastric Bypass | Phase 4 | Unknown | Lucie Favre | 94 | 2024-05-02 | 2024-08-20 |
| Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer IV iron - Anaemia in Ovarian Carcinoma | Phase 3 | Not yet recruiting | University of Saskatchewan | 200 | 2024-02-29 | 2024-02-08 |
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy - Nasopharyngeal Carcinoma, Iron-deficiency | Phase 2 | Unknown | Sun Yat-sen University | 120 | 2023-05-05 | 2023-06-22 |
| Intravenous Iron Infusion on Chemotherapy-induced Anemia iron (isomaltoside), Dried Ferrous Sulfate - Colon Cancer, Chemotherapeutic-Induced Anemia | Phase 2 | Unknown | Korea University Guro Hospital | 80 | 2023-04-20 | 2022-03-29 |
| Neuroimaging Ancillary Study Ferric carboxymaltose, Iron isomaltoside, Ferric Sulfate - Iron Deficiency Anemia, Iron Deficiency Anemia of Pregnancy | Completed | Thomas Jefferson University | 184 | 2023-02-21 | 2025-04-16 | |
| RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study Ferric carboxymaltose, Iron isomaltoside, Ferric Sulfate - Iron Deficiency Anemia, Neurodevelopmental Abnormality | Unknown | Thomas Jefferson University | 538 | 2022-10-11 | 2023-11-29 | |
| Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Ferric Derisomaltose Injection, Normal saline - Gynecologic Cancer, Anemia, Iron Deficiency | Phase 3 | Unknown | Alberta Health Services, Calgary | 82 | 2022-09-30 | 2022-07-20 |
| Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy Iron Isomaltoside 1000, ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia in Childbirth | Phase 3 | Recruiting | Saskatchewan Health Authority - Regina Area | 280 | 2022-06-06 | 2025-05-15 |
| A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery Ferric Derisomaltose, Ferrous sulfate, normal saline - Anemia Postoperative | Phase 4 | Completed | Michael Kremke | 110 | 2021-05-21 | 2023-06-28 |
| Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial Ferric carboxymaltose, Iron isomaltoside, Ferric Sulfate - Iron Deficiency Anemia, Infant, Low Birth Weight | Phase 4 | Completed | Thomas Jefferson University | 4368 | 2021-03-15 | 2024-05-24 |
| Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia Iron Carboxymaltose, Iron Isomaltoside, Ferrous sulphate - Postpartum Anemia Nos, Iron-deficiency | Phase 3 | Completed | University Medical Centre Ljubljana | 300 | 2020-09-10 | 2022-06-27 |
| Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage Iron Isomaltoside 1000, Placebo, Iberet-Folic-500 - Post Partum Hemorrhage, Anemia | Phase 4 | Unknown | University of Malaya | 60 | 2020-08-01 | 2020-08-12 |
| Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). Iron isomaltoside 1000 - Iron-Deficiency Anemia, Iron-Deficiency | Completed | Pierre Fabre Pharma AG | 327 | 2020-07-10 | 2023-07-19 | |
| Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation Normal saline, Iron isomaltoside - Aortic Stenosis (Treated With TAVI) | Phase 4 | Unknown | Yonsei University | 214 | 2020-04-27 | 2020-04-30 |
| Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion Iron Isomaltoside 1000, placebo - Complications | Early Phase 1 | Completed | Ain Shams University | 80 | 2019-09-20 | 2020-01-22 |
| Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients Iron Isomaltoside, Iron sucrose - Iron Deficiency Anemia Treatment | Not applicable | Terminated | The University of Hong Kong | 16 | 2019-02-01 | 2021-10-06 |
| A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease Iron Isomaltoside, Ferric Carboxymaltose - IBD | Phase 4 | Completed | Pharmacosmos A/S | 97 | 2018-05-23 | 2021-02-21 |
Showing 20 of 54. Sign in to see all of them.
Anemia, Iron-Deficiency (21) · Anemia (17) · Iron Deficiencies (8) · Hypophosphatemia (3) · Inflammatory Bowel Diseases (3) · Postpartum Hemorrhage (3) · Neoplasms (2) · Renal Insufficiency, Chronic (2) · Adenocarcinoma (1) · Aortic Valve Stenosis (1) · Autism Spectrum Disorder (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Deficiency Diseases (1) · Disease (1)
Pharmacosmos A/S (23) · Yonsei University (4) · Thomas Jefferson University (3) · Ain Shams University (1) · Alberta Health Services, Calgary (1) · Bayside Health (1) · China-Japan Friendship Hospital (1) · Dow University of Health Sciences (1) · Hull University Teaching Hospitals NHS Trust (1) · Kaunas University of Medicine (1) · Korea University Guro Hospital (1) · Lucie Favre (1) · Michael Kremke (1) · Nottingham University Hospitals NHS Trust (1) · Oslo University Hospital (1)
Denmark (9) · United States (8) · South Korea (5) · India (4) · United Kingdom (4) · Canada (2) · China (2) · Switzerland (2) · Australia (1) · Egypt (1) · France (1) · Germany (1) · Hong Kong (1) · Japan (1) · Lithuania (1)
Richard Derman, MD, MPH (3) · Lars Lykke Thomsen, MD (2) · Andrius Macas, MDPhDProf (1) · Austin G Acheson, MD FRCS (1) · Ayman Shoeb, professor (1) · Barrie D Keeler, FRCS (1) · Danilo Fliser, MD (1) · Gunnar Heine, MD (1) · Jason Moore, BMedSci, BMBS, FRCP (1) · Jin-Tae Kim, Pf. (1) · Lars Gullestad, MD, PhD (1) · Lars Lykke Thomsen (1) · Maggie Ming Yee Mok, MBBS FHKAM (1) · Maryam Al-Hayki (1)
PMID 29558233, PMID 32016310, PMID 25588587, PMID 26927900, PMID 29213281, PMID 29973224, PMID 30630452, PMID 31243803, PMID 32049331, PMID 32654663, PMID 32843079, PMID 33259451, PMID 33302891, PMID 33455926, PMID 33781988, PMID 34088733, PMID 35781129, PMID 36107229, PMID 37524101, PMID 38124098, PMID 38689774, PMID 38874697, PMID 40542212, PMID 41182019, PMID 42618081
2015 (1)